<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="static/style.xsl"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-11-21T02:44:16Z</responseDate><request verb="GetRecord" identifier="oai:macsphere.mcmaster.ca:11375/20796" metadataPrefix="dim">https://prod-ms-be.lib.mcmaster.ca/server/oai/request</request><GetRecord><record><header><identifier>oai:macsphere.mcmaster.ca:11375/20796</identifier><datestamp>2026-09-24T05:41:54Z</datestamp><setSpec>com_11375_271</setSpec><setSpec>col_11375_272</setSpec></header><metadata><dim:dim xmlns:dim="http://www.dspace.org/xmlns/dspace/dim" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:doc="http://www.lyncode.com/xoai" xsi:schemaLocation="http://www.dspace.org/xmlns/dspace/dim http://www.dspace.org/schema/dim.xsd">
   <dim:field mdschema="dc" element="contributor" qualifier="advisor">Trigatti, Bernardo L</dim:field>
   <dim:field mdschema="dc" element="contributor" qualifier="author">Gonzalez Jara, Leticia A</dim:field>
   <dim:field mdschema="dc" element="contributor" qualifier="department" lang="en_US">Biochemistry and Biomedical Sciences</dim:field>
   <dim:field mdschema="dc" element="date" qualifier="accessioned">2016-11-10T18:34:19Z</dim:field>
   <dim:field mdschema="dc" element="date" qualifier="available">2016-11-10T18:34:19Z</dim:field>
   <dim:field mdschema="dc" element="date" qualifier="issued">2016</dim:field>
   <dim:field mdschema="dc" element="identifier" qualifier="uri">http://hdl.handle.net/11375/20796</dim:field>
   <dim:field mdschema="dc" element="identifier" qualifier="uri">https://doi.org/10.71548/15259</dim:field>
   <dim:field mdschema="dc" element="description" qualifier="abstract" lang="en_US">Atherosclerosis is a chronic inflammatory disease affecting large- and medium-sized&#xd;
arteries and is considered the major cause behind cardiovascular diseases (CVD).&#xd;
Elevated low-density lipoprotein (LDL)-cholesterol and low high-density lipoprotein&#xd;
(HDL)-cholesterol are considered major risk factors for the CVD. HDL mediates a&#xd;
variety of atheroprotective actions, many of them involving the interaction with the&#xd;
scavenger receptor class B, type 1 (SR-B1).&#xd;
Despite the efforts placed in raising HDL-cholesterol, no improvement has been&#xd;
achieved in reducing CVD risk, suggesting that other components of the HDL particles&#xd;
may be responsible for HDL-mediated atheroprotection. One of these may be&#xd;
sphingosine-1-phospate (S1P).&#xd;
In this thesis, the role of S1P receptors (S1PRs) in atherosclerosis is explored,&#xd;
with emphasis in macrophage apoptosis. In particular, the importance of the macrophage&#xd;
S1PR1 and its role in apoptosis and atherosclerosis was evaluated. We demonstrated that&#xd;
diabetes exacerbates atherosclerosis development and myocardial infarction in SR-B1&#xd;
KO/apoE-hypomorphic mice and that treatment with FTY720, a S1PR agonist, protects&#xd;
against diabetes pro-atherogenic effects. We also show that S1PR1 agonists protected&#xd;
macrophages against apoptosis through phosphoinositide 3-kinase (PI3K)/AKT, and that&#xd;
HDL failed to protect S1PR1 deficient macrophages against apoptosis. In vivo,&#xd;
macrophage S1PR1 deficiency translated into increased atherosclerosis, necrotic core&#xd;
formation and numbers of apoptotic cells in the atherosclerotic plaque.&#xd;
&#xd;
BIM deficiency in BM cells was protective against atherosclerosis development&#xd;
and HDL treatment reduced BIM protein levels in cells exposed to ER stressors,&#xd;
suggesting that the pro-apoptotic protein may be an important target for HDL in&#xd;
macrophages.&#xd;
We conclude that signaling through the S1PRs, in particular S1PR1 is important&#xd;
in controlling macrophage apoptosis and atherosclerosis development. Our data suggests&#xd;
that S1PR1 signaling axis and the pro-apoptotic protein BIM play an important role in&#xd;
mediating HDL anti-apoptotic signaling, however further studies are required to clarify&#xd;
the interaction between all of these factors.</dim:field>
   <dim:field mdschema="dc" element="description" qualifier="degreetype" lang="en_US">Thesis</dim:field>
   <dim:field mdschema="dc" element="description" qualifier="degree" lang="en_US">Doctor of Philosophy (PhD)</dim:field>
   <dim:field mdschema="dc" element="language" qualifier="iso" lang="en_US">en</dim:field>
   <dim:field mdschema="dc" element="subject" lang="en_US">atherosclerosis</dim:field>
   <dim:field mdschema="dc" element="subject" lang="en_US">macrophage apoptosis</dim:field>
   <dim:field mdschema="dc" element="subject" lang="en_US">sphingosine-1-phosphate receptors</dim:field>
   <dim:field mdschema="dc" element="subject" lang="en_US">high density lipoprotein</dim:field>
   <dim:field mdschema="dc" element="title" lang="en_US">INVESTIGATING THE MOLECULAR MECHANISMS OF ATHEROSCLEROSIS DEVELOPMENT IN THE MOUSE: EMPHASIS ON THE MACROPHAGE SPHINGOSINE-1-PHOSPHATE RECEPTOR 1</dim:field>
   <dim:field mdschema="dc" element="title" qualifier="alternative" lang="en_US">MOLECULAR MECHANISMS OF ATHEROSCLEROSIS IN THE MOUSE</dim:field>
   <dim:field mdschema="dc" element="type" lang="en_US">Thesis</dim:field>
   <dim:field mdschema="others" element="access-status">open.access</dim:field>
</dim:dim></metadata></record></GetRecord></OAI-PMH>